| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $243,584 ) |
| | 2024 | 2024 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | R15HL172207 | Maturation Strategies for Engineered Human Cardiac Microtissues | 000 | 1 | NIH | 11/24/2023 | $448,200 |
| | 2024 | 2022 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | A2230989 | Nurse Anesthetist Traineeships | 01 | 6 | HRSA | 12/8/2023 | $0 |
| | 2024 | 2022 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0001 | SUMMIT | USA | H79SM080429 | UA 2018 GLS Campus Suicide Prevention Grant | 000 | 3 | SAMHSA | 10/11/2023 | -$74,031 |
| | 2024 | 2022 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | R03EB030321 | Fully-Analog Motion Artifact Elimination Circuit for Compact and Low Power A-ECG Monitoring Devices | 000 | 2 | NIH | 2/22/2024 | $0 |
| | 2024 | 2021 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0001 | SUMMIT | USA | R33CA225549 | A High Throughput Human Tumor Modeling Technology for Cancer Drug Discovery | 000 | 3 | NIH | 4/30/2024 | $0 |
| | 2024 | 2021 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | R15DK124790 | Using Established Leptin Signaling Mutants to Study Cell Physiology and Bone Development in Zebrafish | 000 | 1 | NIH | 2/21/2024 | $0 |
| | 2024 | 2021 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0001 | SUMMIT | USA | H79FG000096 | Addiction Treatment Counts: Interprofessional Training | 000 | 2 | SAMHSA | 2/15/2024 | -$43,749 |
| | 2024 | 2021 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0001 | SUMMIT | USA | R21AR074743 | Development of synergistic oxygenating antibacterial hydrogel dressings for reducing infection in diabetic wounds | 000 | 2 | NIH | 12/19/2023 | $0 |
| | 2024 | 2019 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | T9833419 | Opioid Workforce Expansion Program- Professional | 04 | 1 | HRSA | 2/15/2024 | -$35,688 |
| | 2024 | 2019 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0001 | SUMMIT | USA | R15NS109957 | Novel MR Image Processing as an Objective Diagnostic Test for Chiari Malformation | 000 | 1 | NIH | 2/22/2024 | -$51,148 |
|
| Issue Date FY: 2023 ( Subtotal = $439,448 ) |
| | 2023 | 2023 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | R15GM148965 | Developing Activatable Fluorescent Flavonoids for Vascular Imaging | 000 | 1 | NIH | 2/22/2023 | $439,448 |
| | 2023 | 2021 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | R33CA225549 | A High Throughput Human Tumor Modeling Technology for Cancer Drug Discovery | 002 | 3 | NIH | 5/11/2023 | $0 |
| | 2023 | 2021 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | R33CA225549 | A High Throughput Human Tumor Modeling Technology for Cancer Drug Discovery | 001 | 3 | NIH | 5/11/2023 | $0 |
| | 2023 | 2021 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | R33CA225549 | A High Throughput Human Tumor Modeling Technology for Cancer Drug Discovery | 000 | 3 | NIH | 5/11/2023 | $0 |
| | 2023 | 2019 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | T9833419 | Opioid Workforce Expansion Program- Professional | 03 | 1 | HRSA | 7/17/2023 | $0 |
| | 2023 | 2018 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | R15CA216413 | Modeling Treatment-Induced Drug Resistance of Colon Cancer Cells and Treatment Strategies | 000 | 1 | NIH | 12/5/2022 | $0 |
| | 2023 | 2018 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | R15GM126438 | NIR-Emitting Fluorescent Probes with Large Stokes Shift for Improved Zebrafish Neuromast Imaging | 000 | 1 | NIH | 4/20/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $323,173 ) |
| | 2022 | 2022 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | H79SM080429 | UA 2018 GLS Campus Suicide Prevention Grant | 000 | 3 | SAMHSA | 1/7/2022 | $87,238 |
| | 2022 | 2022 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | R21EY033127 | Novel tools for screening retinal function using improved human retinal organoid models | 000 | 2 | NIH | 9/1/2022 | $112,956 |
| | 2022 | 2022 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | A2230989 | Nurse Anesthetist Traineeships | 00 | 6 | HRSA | 5/23/2022 | $49,579 |
| | 2022 | 2022 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | R03EB030321 | Fully-Analog Motion Artifact Elimination Circuit for Compact and Low Power A-ECG Monitoring Devices | 000 | 2 | NIH | 4/20/2022 | $73,400 |
| | 2022 | 2022 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | H79SM080429 | UA 2018 GLS Campus Suicide Prevention Grant | 001 | 3 | SAMHSA | 7/27/2022 | $0 |
| | 2022 | 2021 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | R01AI144115 | Integration of Leukotriene and Prostaglandin Receptor Signaling in Mast cell Activation and Pulmonary Inflammation during Asthma | 001 | 3 | NIH | 5/19/2022 | $0 |
| | 2022 | 2021 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | H79FG000096 | Addiction Treatment Counts: Interprofessional Training | 000 | 2 | SAMHSA | 4/13/2022 | $0 |
| | 2022 | 2019 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | R15NS109957 | Novel MR Image Processing as an Objective Diagnostic Test for Chiari Malformation | 000 | 1 | NIH | 7/13/2022 | $0 |
| | 2022 | 2019 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | T9833419 | Opioid Workforce Expansion Program- Professional | 02 | 1 | HRSA | 8/1/2022 | $0 |
| | 2022 | 2019 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | T9833419 | Opioid Workforce Expansion Program- Professional | 01 | 1 | HRSA | 7/26/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $1,704,714 ) (Continued on the next page) |
| | 2021 | 2021 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | R01AI144115 | Integration of Leukotriene and Prostaglandin Receptor Signaling in Mast cell Activation and Pulmonary Inflammation during Asthma | 000 | 3 | NIH | 1/13/2021 | $380,000 |
| | 2021 | 2021 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | R03EB030321 | Fully-Analog Motion Artifact Elimination Circuit for Compact and Low Power A-ECG Monitoring Devices | 001 | 1 | NIH | 5/25/2021 | -$73,400 |
| | 2021 | 2021 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | R03EB030321 | Fully-Analog Motion Artifact Elimination Circuit for Compact and Low Power A-ECG Monitoring Devices | 001 | 1 | NIH | 5/25/2021 | $73,400 |
| | 2021 | 2021 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | R21AR074743 | Development of synergistic oxygenating antibacterial hydrogel dressings for reducing infection in diabetic wounds | 001 | 2 | NIH | 6/9/2021 | $11,534 |
| | 2021 | 2021 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | R21AR074743 | Development of synergistic oxygenating antibacterial hydrogel dressings for reducing infection in diabetic wounds | 000 | 2 | NIH | 3/17/2021 | $148,295 |
| | 2021 | 2021 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | R33CA225549 | A High Throughput Human Tumor Modeling Technology for Cancer Drug Discovery | 002 | 3 | NIH | 6/17/2021 | $166,399 |
| | 2021 | 2021 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | R33CA225549 | A High Throughput Human Tumor Modeling Technology for Cancer Drug Discovery | 001 | 3 | NIH | 6/10/2021 | $59,188 |
| | 2021 | 2021 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | R33CA225549 | A High Throughput Human Tumor Modeling Technology for Cancer Drug Discovery | 000 | 3 | NIH | 6/3/2021 | $365,045 |
| | 2021 | 2021 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | R01AI144115 | Integration of Leukotriene and Prostaglandin Receptor Signaling in Mast cell Activation and Pulmonary Inflammation during Asthma | 001 | 3 | NIH | 8/19/2021 | -$367,668 |
| | 2021 | 2021 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | A2230989 | Nurse Anesthetist Traineeships | 00 | 5 | HRSA | 5/11/2021 | $49,082 |
| | 2021 | 2021 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | R21EY033127 | Novel tools for screening retinal function using improved human retinal organoid models | 000 | 1 | NIH | 8/5/2021 | $319,835 |
| | 2021 | 2021 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | R15DK124790 | Using Established Leptin Signaling Mutants to Study Cell Physiology and Bone Development in Zebrafish | 000 | 1 | NIH | 4/19/2021 | $443,905 |
| | 2021 | 2021 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | R03EB030321 | Fully-Analog Motion Artifact Elimination Circuit for Compact and Low Power A-ECG Monitoring Devices | 000 | 1 | NIH | 3/17/2021 | $73,400 |
| | 2021 | 2021 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | H79FG000096 | Addiction Treatment Counts: Interprofessional Training | 000 | 2 | SAMHSA | 3/11/2021 | $100,000 |
| | 2021 | 2021 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | H79SM080429 | UA 2018 GLS Campus Suicide Prevention Grant | 000 | 2 | SAMHSA | 1/11/2021 | $90,519 |
| | 2021 | 2020 | The University Of Akron | 302 Buchtel Common | Akron | OH | 44325-0002 | SUMMIT | USA | A2230989 | Nurse Anesthetist Traineeships | 01 | 4 | HRSA | 3/3/2021 | $0 |
| | 2021 | 2018 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | R15GM126438 | NIR-Emitting Fluorescent Probes with Large Stokes Shift for Improved Zebrafish Neuromast Imaging | 000 | 1 | NIH | 12/2/2020 | $0 |
| | 2021 | 2016 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | R15GM119074 | Metabolic and Chemical Analyses of Cuprizone Toxicity | 000 | 1 | NIH | 2/4/2021 | -$121,088 |
| | 2021 | 2016 | THE UNIVERSITY OF AKRON | 302 BUCHTEL COMMON | AKRON | OH | 44325-0002 | SUMMIT | USA | R15GM119030 | New methods for the modification of peptides and proteins with the Re(CO)3 moiety | 000 | 1 | NIH | 5/10/2021 | -$13,100 |
|
